UBS Cuts Orkla Rating and Price Target, Flags Margin Pressure and Weaker Jotun Contribution

Summary

UBS has lowered its recommendation on Orkla to Sell from Neutral and reduced its 12-month price target to NOK 89 from NOK 130. The new target implies about 14% downside relative to the stock's last close of NOK 103.10. The bank points to rising freight, packaging and energy costs, combined with softer consumer demand across Europe and a weaker profit contribution from Orkla's associate Jotun, as key pressures on earnings over the coming two years.

Analyst action and price target

UBS's move to downgrade Orkla accompanies a sizeable cut to the broker's 12-month price target, from NOK 130 to NOK 89. Using the company's most recent closing price of NOK 103.10, UBS's target equates to an implied decline of roughly 14%.

Drivers of the downgrade

• Rising input and operating costs - UBS lists higher freight, packaging and energy costs as mounting headwinds.
• Weaker consumer demand - The bank warns of softer consumer spending across Europe, which will constrain Orkla's ability to pass through costs via pricing.
• Associate risk from Jotun - UBS highlights that Jotun accounts for roughly 30% of Orkla's net income and expects a notable reduction in its profit contribution.

Margin and earnings outlook

UBS projects Orkla's consolidated portfolio margins to decline by approximately 90 basis points between 2025 and 2027. Although the bank notes this contraction should still be less severe than the inflation shock seen in 2021-2022, it expects the combination of weaker European consumers and higher costs will limit Orkla's ability to offset inflation through pricing.

Specifically, UBS has trimmed Orkla's earnings-per-share forecasts by 7% for 2026 and by 15% for 2027. The analysts attribute these cuts to a mix of weaker organic sales growth, elevated cost inflation and unfavorable foreign exchange impacts related to a stronger Norwegian krone.

Jotun's contribution and sales growth expectations

UBS emphasises the significance of Orkla's stake in Jotun, which contributes around 30% of Orkla's net income. The brokerage forecasts Jotun's profit contribution will decline by 14% in 2026 and by 6% in 2027, citing pressures from supply-chain disruptions, energy costs and the ongoing Middle East conflict.

On organic sales growth, UBS now expects Orkla to deliver 2.9% in 2026 and 2.7% in 2027. The bank points out these rates are below the growth pace of larger European peers such as Nestle9 and Danone, and says Orkla's relatively lower pricing power and slimmer margins make it more exposed to inflationary pressures than many competitors.

Conclusion

UBS's downgrade and forecast adjustments reflect a view that Orkla faces a mix of input-cost inflation, demand weakness in Europe and material exposure to performance at Jotun. The bank's reduced EPS estimates and lower price target encapsulate those concerns and signal a more cautious outlook for the next two years.